You are here: Home / News / FDA panel rules against NeurogesX patch for HIV

FDA panel rules against NeurogesX patch for HIV

February 9, 2012 By

Related posts:

  1. U.S. panel: More study on Human Genome anthrax drug
  2. FDA panel rejects Eisai’s leukemia drug
  3. Scientists find gene that controls chronic pain
  4. FDA panel rejects Novartis drug for gout
  5. Some men can delay prostate cancer treatment: panel

Filed Under: News Tagged With: ,